Genentech seeks ‘tens of millions in unpaid royalties’ in licence dispute

07-03-2023

Liz Hockley

Genentech seeks ‘tens of millions in unpaid royalties’ in licence dispute

Michael Vi / Shutterstock.com

The Roche subsidiary says the licensee owes payments on “stockpile” of MS drug Tysabri.


Genentech, Biogen, Tysabri, Cabilly, multiple sclerosis, Crohn’s, natalizumab, patent

LSIPR